The emergence of EU governance in public health: The case of blood policy and regulation

Anne-Maree Farrell*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract / Description of output

On 27 January 2003 the Council and the European Parliament formally adopted a new Directive setting standards of quality and safety in relation to blood and blood products1 (the ‘Blood Directive’). Since 1989 a series of laws had been passed at European Union (EU) level concerning the marketing and licensing of ‘medicinal products’ such as fractionated blood products, although this had been done mainly to further the completion of the internal market (Weatherill 1997). The political fallout from HIV contamination of blood supplies in member states was to provide the catalyst for greater EU involvement in blood policy and regulation in the 1990s, culminating in the adoption of the Blood Directive. Unlike earlier EU legislative initiatives in blood-related matters, this Directive establishes a comprehensive EU-wide regulatory framework for the collection, manufacture and supply of blood and blood products for the first time. Member states had until 8 February 2005 in which to implement the terms of the Directive.
Original languageEnglish
Title of host publicationHealth Governance in Europe
Subtitle of host publicationIssues, Challenges, and Theories
EditorsMonika Steffen
Place of PublicationLondon
Number of pages18
ISBN (Electronic)9780203015582
ISBN (Print)9780415364522, 9781138975880
Publication statusPublished - 10 Mar 2005

Publication series

NameRoutledge/ECPR Studies in European Political Science


Dive into the research topics of 'The emergence of EU governance in public health: The case of blood policy and regulation'. Together they form a unique fingerprint.

Cite this